Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OLANZAPINE vs RISPERIDONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OLANZAPINE vs RISPERIDONE: Safety Overview

Metric OLANZAPINE RISPERIDONE
Total FAERS Reports 51,444 79,288
Deaths Reported 5,535 4,120
Death Rate 10.8% 5.2%
Hospitalizations 21,934 18,771
Average Patient Age 44.3 yrs 31.9 yrs
% Female Patients 46.1% 15.6%
FDA Approval Date Apr 23, 2012 Apr 12, 2007
Manufacturer REMEDYREPACK INC. NuCare Pharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription